AI agents are scaling in outpatient care

Outpatient settings operate on thin margins (3-5%) with small administrative teams. A typical primary care physician spends 2 hours on documentation for every 1 hour of patient contact. Staff turnover averages 25-30% annually. Outpatient care also has simpler IT environments than hospitals — shorter procurement cycles, fewer integration points, and faster decision-making. A 20-physician group can pilot an AI scribe in a week; a 500-bed hospital takes 6-12 months. Outpatient visits in the US exceeded 1 billion in 2024. The ambulatory care IT market is projected to reach $78 billion by 2027.

Hippocratic AI ($53M Series A, $500M valuation) builds patient-facing AI agents handling 2M+ monthly interactions across 150+ outpatient partners. Commure ($300M+ total funding) has taken a platform approach spanning documentation, communication, and operational workflows across 40+ health systems. Nabla has emerged as a leading AI scribe with 95%+ note acceptance rates. Tandem Health targets European outpatient care with multilingual support.

AI scribes reduce documentation time by 40-60% — and they’re a Trojan horse for broader workflow automation. Clinical decision support at the point of care (OpenEvidence, AMBOSS Lisa) is the second major use case. Billing and coding automation (Akasa, Regard, Nym Health) can recover 5-10% of revenue. Patient communication agents (Hyro) resolve 65% of calls without human intervention.

Hospitals face 6-18 month procurement cycles and complex integration requirements. Outpatient settings offer faster decisions, simpler tech stacks, and direct ROI measurement. The outpatient market is functioning as the proving ground where AI agent companies refine products and build revenue before tackling hospitals. We expect the outpatient AI agent market to reach $12-15 billion by 2028.